| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.3M | +11.9% |
| Cost of Revenue | $1.6M | -7.2% |
| Gross Profit | $1.7M | +37.9% |
| R&D Expense | $2.6M | -17.7% |
| SG&A Expense | $7.8M | +10.5% |
| Operating Income | -$13.8M | +12.5% |
| Net Income | -$13.7M | +12.2% |
| EPS (Basic) | -$11.26 | -31.1% |
| EPS (Diluted) | -$11.26 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.5M | +169.2% |
| Accounts Receivable | $863K | +66.6% |
| Inventory | $606K | +9.4% |
| Current Assets | $8.2M | +111.1% |
| Total Assets | $9.8M | +55.1% |
| Current Liabilities | $1.9M | -40.5% |
| Total Liabilities | $3.9M | -30.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.9M | +18.9% |
| Capital Expenditures | $186K | -48.5% |
| Investing Cash Flow | -$186K | -103.0% |
| Financing Cash Flow | $14.1M | +124.1% |
| Free Cash Flow | -$10.1M | +19.8% |
| -31.1% |
| Stockholders' Equity |
| $6.0M |
| +667.5% |